Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Onkologie|April 15, 2010
Clinical outcomes and breast cancer subtypes in patients with brain metastasesHyuk-Chan Kwon, Sung Yong Oh, Sung-Hyun Kim, et al.
Molecular and Clinical Oncology|March 21, 2014
Prognostic significance of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in biliary tract cancer patients receiving adjuvant 5-fluorouracil-based chemotherapyKwan Woo Kim, Hyuk-Chan Kwon, Sung-Hyun Kim, et al.
The Korean Journal of Hematology|January 22, 2011
Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adultsJi Hyun Lee, Kyung A Kwon, Suee Lee, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2018
Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancerSung Yong Oh, Suee Lee, Seok Jae Huh, et al.
World Journal of Gastroenterology|October 28, 2009
Gastric leptomeningeal carcinomatosis: multi-center retrospective analysis of 54 casesSung Yong Oh, Su-Jin Lee, Jeeyun Lee, et al.
Acta Haematologica|December 20, 2011
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 22, 2015
DNA ligase4 as a prognostic marker in nasopharyngeal cancer patients treated with radiotherapyDong Hyun Kim, Sung Yong Oh, So Yeon Kim, et al.
Cancer Research and Treatment|February 21, 2018
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)In Hae Park, Seock-Ah Im, Kyung Hae Jung, et al.
Cancer Research and Treatment|June 6, 2019
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 TherapySung-Bae Kim, In-Gu Do, Janice Tsang, et al.
British Journal of Cancer|November 7, 2019
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)Sung Hoon Sim, In Hae Park, Kyung Hae Jung, et al.
Pageof 9